RNXT
RNXT
NASDAQ · Biotechnology

Renovorx Inc

$1.57
+0.02 (+1.29%)
As of Sep 29, 10:18 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +2,285.4% upside
Low Target $24.30
Average Target $37.45
High Target $44.03
Current Price $1.57
Current
$1.57
Target
$37.45
$24.30 $37.45 avg $44.03
Scenario Analysis
Bear Case
$24.30
1,447.8%
Low target
Base Case
$37.45
+2,285.4%
Avg target
Bull Case
$44.03
+2,704.5%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$2.59
-39.4% from high
52-Week Low
$0.70
+124.1% from low
Target vs 52W High
$37.45
+1,345.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.2%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.9%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +139.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.8%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -26.5%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.5%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.2%